Ignite Creation Date:
2024-05-06 @ 3:59 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04835714
Status:
TERMINATED
Last Update Posted:
2023-02-01
First Post:
2021-04-06
Brief Title:
A Study to Find a Safe and Effective Dose of BI 1701963 Alone and in Combination With BI 3011441 in Patients With Advanced Cancer and a Certain Mutation Kirsten Rat Sarcoma Viral Oncogene Homologue KRAS
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-18
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-06
First Submit QC Date:
April 6 2021
Study First Post Date:
2021-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-31
Last Update Post Date:
2023-02-01
Last Update Post Date Type:
ACTUAL